SOCIETY FOR ENDOCRINOLOGY ENDOCRINE EMERGENCY GUIDANCE: Emergency management of acute hypercalcaemia in adult patients

doi:10.1530/EC-16-0055

. 2016 Sep;5(5):G9-G11.

doi: 10.1530/EC-16-0055.

SOCIETY FOR ENDOCRINOLOGY ENDOCRINE EMERGENCY GUIDANCE: Emergency management of acute hypercalcaemia in adult patients

Jennifer Walsh¹, Neil Gittoes², Peter Selby³; Society for Endocrinology Clinical Committee

Affiliations

¹ The Mellanby Centre for Bone ResearchThe Medical School, The University of Sheffield, Sheffield, UK j.walsh@sheffield.ac.uk.
² Centre for EndocrinologyDiabetes and Metabolism, University Hospitals Birmingham & University of Birmingham, Birmingham Health Partners, Birmingham, UK.
³ Department of MedicineManchester Royal Infirmary, Manchester, UK.

PMID: 27935816
PMCID: PMC5314807
DOI: 10.1530/EC-16-0055

SOCIETY FOR ENDOCRINOLOGY ENDOCRINE EMERGENCY GUIDANCE: Emergency management of acute hypercalcaemia in adult patients

Jennifer Walsh et al. Endocr Connect. 2016 Sep.

. 2016 Sep;5(5):G9-G11.

doi: 10.1530/EC-16-0055.

Authors

Jennifer Walsh¹, Neil Gittoes², Peter Selby³; Society for Endocrinology Clinical Committee

Affiliations

¹ The Mellanby Centre for Bone ResearchThe Medical School, The University of Sheffield, Sheffield, UK j.walsh@sheffield.ac.uk.
² Centre for EndocrinologyDiabetes and Metabolism, University Hospitals Birmingham & University of Birmingham, Birmingham Health Partners, Birmingham, UK.
³ Department of MedicineManchester Royal Infirmary, Manchester, UK.

PMID: 27935816
PMCID: PMC5314807
DOI: 10.1530/EC-16-0055

No abstract available

PubMed Disclaimer

Cited by

Cardiac Manifestations after Ingestion of a Commercial Desiccant: A Case Report.
Shin SJ, Kim YJ. Shin SJ, et al. Medicina (Kaunas). 2023 Dec 28;60(1):55. doi: 10.3390/medicina60010055. Medicina (Kaunas). 2023. PMID: 38256316 Free PMC article.
Treatment of hypercalcaemia of malignancy in adults.
Mc Donald D, Drake MT, Crowley RK. Mc Donald D, et al. Clin Med (Lond). 2023 Sep;23(5):503-507. doi: 10.7861/clinmed.2023-0227. Epub 2023 Sep 29. Clin Med (Lond). 2023. PMID: 37775175 Free PMC article.
Derivation and comparison of formulae for the adjustment of total calcium.
Phylactou M, Comninos AN, Salih A, Labib M, Eng PC, Clarke SA, Moore P, Tan T, Cegla J, Dhillo WS, Abbara A. Phylactou M, et al. Front Endocrinol (Lausanne). 2023 May 12;14:1070443. doi: 10.3389/fendo.2023.1070443. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37251673 Free PMC article.
Primary hyperparathyroidism presenting as acute hypercalcemic crisis: a case report.
Gill G, Agrawal V, Kerr P. Gill G, et al. J Otolaryngol Head Neck Surg. 2023 Jan 11;52(1):1. doi: 10.1186/s40463-022-00600-x. J Otolaryngol Head Neck Surg. 2023. PMID: 36627692 Free PMC article.
[Diagnostics and treatment of clinically relevant paraneoplastic syndromes].
Schütte K, Trautmann-Grill K. Schütte K, et al. Schmerz. 2022 Dec;36(6):447-457. doi: 10.1007/s00482-022-00669-3. Epub 2022 Oct 19. Schmerz. 2022. PMID: 36260170 Review. German.

See all "Cited by" articles

References

1. LeGrand SB, Leskuski D, Zama I. Narrative review: furosemide for hypercalcemia: an unproven yet common practice. Annals of Internal Medicine 2008. 149 259–263. (10.7326/0003-4819-149-4-200808190-00007) - DOI - PubMed
1. Nussbaum SR, Younger J, Vandepol CJ, Gagel RF, Zuber MA, Chapman R, Henderson IC, Malette IE. Single-dose intravenous therapy for the treatment of hypercalcaemia of malignancy: comparison of 30-, 60-, and 90mg doses. American Journal of Medicine 1993. 95 297–304. (10.1016/0002-9343(93)90282-T) - DOI - PubMed
1. Major P, Lortholary A, Hon J, Abdi E, Mills G, Menssen HD, Yunus F, Bell R, Body J, Quebe-Fehling E, et al. Zoledronic acid is superior to pamidronate in the treatment of hypercalcemia of malignancy: a pooled analysis of two randomized, controlled clinical trials. Journal of Clinical Oncology 2001. 19 558–567. - PubMed
1. Wineski LA. Salmon calcitonin in the management of hypercalcaemia. Calcified Tissue International 1990. 46 (Supplement) S26–S30. - PubMed
1. Marcocci C, Chanson P, Shoback D, Bilezikian J, Fernandez-Cruz L, Orgiazzi J, Henzen C, Cheng S, Sterling LR, Lu J, et al. Cinacalcet reduces serum calcium concentrations in patients with intractable primary hyperparathyroidism. Journal of Clinical Endocrinology and Metabolism 2009. 94 2766–2772. (10.1210/jc.2008-2640) - DOI - PMC - PubMed

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations

[1] LeGrand SB, Leskuski D, Zama I. Narrative review: furosemide for hypercalcemia: an unproven yet common practice. Annals of Internal Medicine 2008. 149 259–263. (10.7326/0003-4819-149-4-200808190-00007) - DOI - PubMed

[2] LeGrand SB, Leskuski D, Zama I. Narrative review: furosemide for hypercalcemia: an unproven yet common practice. Annals of Internal Medicine 2008. 149 259–263. (10.7326/0003-4819-149-4-200808190-00007) - DOI - PubMed

[3] Nussbaum SR, Younger J, Vandepol CJ, Gagel RF, Zuber MA, Chapman R, Henderson IC, Malette IE. Single-dose intravenous therapy for the treatment of hypercalcaemia of malignancy: comparison of 30-, 60-, and 90mg doses. American Journal of Medicine 1993. 95 297–304. (10.1016/0002-9343(93)90282-T) - DOI - PubMed

[4] Nussbaum SR, Younger J, Vandepol CJ, Gagel RF, Zuber MA, Chapman R, Henderson IC, Malette IE. Single-dose intravenous therapy for the treatment of hypercalcaemia of malignancy: comparison of 30-, 60-, and 90mg doses. American Journal of Medicine 1993. 95 297–304. (10.1016/0002-9343(93)90282-T) - DOI - PubMed

[5] Major P, Lortholary A, Hon J, Abdi E, Mills G, Menssen HD, Yunus F, Bell R, Body J, Quebe-Fehling E, et al. Zoledronic acid is superior to pamidronate in the treatment of hypercalcemia of malignancy: a pooled analysis of two randomized, controlled clinical trials. Journal of Clinical Oncology 2001. 19 558–567. - PubMed

[6] Major P, Lortholary A, Hon J, Abdi E, Mills G, Menssen HD, Yunus F, Bell R, Body J, Quebe-Fehling E, et al. Zoledronic acid is superior to pamidronate in the treatment of hypercalcemia of malignancy: a pooled analysis of two randomized, controlled clinical trials. Journal of Clinical Oncology 2001. 19 558–567. - PubMed

[7] Wineski LA. Salmon calcitonin in the management of hypercalcaemia. Calcified Tissue International 1990. 46 (Supplement) S26–S30. - PubMed

[8] Wineski LA. Salmon calcitonin in the management of hypercalcaemia. Calcified Tissue International 1990. 46 (Supplement) S26–S30. - PubMed

[9] Marcocci C, Chanson P, Shoback D, Bilezikian J, Fernandez-Cruz L, Orgiazzi J, Henzen C, Cheng S, Sterling LR, Lu J, et al. Cinacalcet reduces serum calcium concentrations in patients with intractable primary hyperparathyroidism. Journal of Clinical Endocrinology and Metabolism 2009. 94 2766–2772. (10.1210/jc.2008-2640) - DOI - PMC - PubMed

[10] Marcocci C, Chanson P, Shoback D, Bilezikian J, Fernandez-Cruz L, Orgiazzi J, Henzen C, Cheng S, Sterling LR, Lu J, et al. Cinacalcet reduces serum calcium concentrations in patients with intractable primary hyperparathyroidism. Journal of Clinical Endocrinology and Metabolism 2009. 94 2766–2772. (10.1210/jc.2008-2640) - DOI - PMC - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

SOCIETY FOR ENDOCRINOLOGY ENDOCRINE EMERGENCY GUIDANCE: Emergency management of acute hypercalcaemia in adult patients

Affiliations

SOCIETY FOR ENDOCRINOLOGY ENDOCRINE EMERGENCY GUIDANCE: Emergency management of acute hypercalcaemia in adult patients

Authors

Affiliations

Similar articles

Cited by

References

LinkOut - more resources

Full Text Sources

Other Literature Sources

Similar articles

Cited by

References

Related information

LinkOut - more resources

Full Text Sources

Other Literature Sources